TrianglePUBLICATIONS · 25533035
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2015 Feb 19
- First author
- Gopal AK
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Gopal AK
- type
- Author
- name
- Chen R
- type
- Author
- name
- Smith SE
- type
- Author
- name
- Ansell SM
- type
- Author
- name
- Rosenblatt JD
- type
- Author
- name
- Savage KJ
- type
- Author
- name
- Connors JM
- type
- Author
- name
- Engert A
- type
- Author
- name
- Larsen EK
- type
- Author
- name
- Chi X
- type
- Author
- name
- Sievers EL
- type
- Author
- name
- Younes A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Gopal AK
- type
- Author
- name
- Chen R
- type
- Author
- name
- Smith SE
- type
- Author
- name
- Ansell SM
- type
- Author
- name
- Rosenblatt JD
- type
- Author
- name
- Savage KJ
- type
- Author
- name
- Connors JM
- type
- Author
- name
- Engert A
- type
- Author
- name
- Larsen EK
- type
- Author
- name
- Chi X
- type
- Author
- name
- Sievers EL
- type
- Author
- name
- Younes A
- type
- Author
- bibliography ids
- nci-bib-0ae7873d53d7ba72f3426f2d
- book metadata
- content sha256
- 007ed07ed4c0f7d71a1190c1f9a6d754e213bcc21946e124531ecae9d2283b5d
- document type
- citation
- dois
- 10.1182/blood-2014-08-595801
- electronic publication date
- display
- 2014 Dec 22
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25533035
- immutable id
- pubmed:25533035@007ed07ed4c0f7d71a1190c1f9a6d754e213bcc21946e124531ecae9d2283b5d
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 8
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1236-43
- volume
- 125
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25533035
- provenance
- batch id
- 863b068fe5a07222af6a
- provider
- NCBI PubMed ESummary
- record sha256
- 48d672d7993590308cc124ac341c21c1984035f25d8b19fa3f6b721d244cbfef
- response sha256
- 80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
- retrieved at
- 2026-09-09T23:47:07.648963+00:00
- publication date
- display
- 2015 Feb 19
- precision
- day
- year
- 2015
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.
Preserved source evidence · Not medical advice